Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | cyclizine | 6726 | drug-path |
Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | cyclizine | 6726 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | cyclizine | 6726 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | cyclizine | 6726 | drug-path |
Adipocytokine signaling pathway | R-HSA-168638 | map04920 | cyclizine | 6726 | drug-path |
ErbB signaling pathway | R-HSA-168638 | map04012 | cyclizine | 6726 | drug-path |
Non-small cell lung cancer | R-HSA-5619066 | map05223 | cyclizine | 6726 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | cyclizine | 6726 | drug-path |
Gap junction | R-HSA-190861 | map04540 | cyclizine | 6726 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | cyclizine | 6726 | drug-path |
Small cell lung cancer | R-HSA-5619066 | map05222 | cyclizine | 6726 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | tubocurarine chloride | 6000 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | tubocurarine chloride | 6000 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | tubocurarine chloride | 6000 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | tubocurarine chloride | 6000 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | tetracaine | 5411 | drug-path |
Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | tetracaine | 5411 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | tetracaine | 5411 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | tetracaine | 5411 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | parthenolide | 7251185 | drug-path |